BrainStorm Cell Therapeutics
BCLI
#10710
Rank
S$13.95 M
Marketcap
S$1.26
Share price
6.52%
Change (1 day)
47.87%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2026 (TTM): -S$12.27 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -S$13.3 Million, an increase over its 2024 earnings that were of -S$15 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$12.27 Million-7.8%
2025 -S$13.3 Million-11.32%
2024 -S$15 Million-32.39%
2023 -S$22.19 Million-29.18%
2022 -S$31.33 Million-0.74%
2021 -S$31.56 Million-23.12%
2020 -S$41.05 Million36.8%
2019 -S$30.01 Million66.71%
2018 -S$18 Million181.66%
2017 -S$6.39 Million-0.6%
2016 -S$6.43 Million-41.31%
2015 -S$10.96 Million-8.22%
2014 -S$11.94 Million89.74%
2013 -S$6.29 Million42.27%
2012 -S$4.43 Million-12.45%
2011 -S$5.05 Million63.04%
2010 -S$3.1 Million35.52%
2009 -S$2.29 Million-48.99%
2008 -S$4.49 Million-44.39%
2007 -S$8.06 Million
2005 -S$4.18 Million-91.44%
2004 -S$48.75 Million94007.62%
2003 -S$0.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
S$2.09 B-17,059.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$13.84 B-112,200.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-S$1.03 Billion 8,160.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-S$1.08 Billion 8,568.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
S$0.15 B-1,350.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-S$0.33 Billion 2,569.69%๐Ÿ‡บ๐Ÿ‡ธ USA